New papers matching your gene panel (BRCA1, TP53 + breast cancer):
New matches
BRCA1 synthetic lethality with CDK12 inhibition in TNBC
Nature Medicine · May 2026 · PMID 39021456
Relevance: BRCA1 (panel gene) + CDK12 (pathway co-target)
TP53 mutation signature predicts response to immunotherapy in solid tumours
Journal of Clinical Oncology · May 2026 · PMID 39021789
Relevance: TP53 (panel gene) + immunotherapy context
You're receiving this because you subscribed to alerts for this gene panel at gailabai.com.
Unsubscribe